Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin in Angiomyolipomas in Patients With Tuberous Sclerosis
NCT01217125Phase 4Completed
- Sponsor
- Fundació Puigvert
- Start
- Oct 2008
- Primary completion
- May 2011
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of sirolimus in angiomyolipoma (AML), sponsored by Fundació Puigvert. Started Oct 2008; status: completed.
02
Drugs
sirolimus
03
Conditions
angiomyolipoma (AML)
Beyond the preview
Go deeper on NCT01217125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01217125.